Lakefront Biotherapeutics NV (GLPG) Q2 2026 Earnings

6MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-3.6
-2.32
-1.04
0.24

Details

Expected EPS
-0.94169240609
Actual EPS
0.2426277
Surprise EPS
1.18
Surprise Percent
+125.77%

Description

Lakefront Biotherapeutics NV (GLPG) has reported earnings of 0.2426277 per share for Q2 2026.

0 Comments

Share your thoughts